Cure MSA

Country specific patient information

Ahmed Z, Asi YT, Lees AJ, Revesz T, Holton JL. Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease. Brain Pathol 2013;23:263-273.

 

Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 2012;38:4-24.

 

Bjornsdottir A, Gudmundsson G, Blondal H, Olafsson E. Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland. J Neurol Neurosurg Psychiatry 2013;84:136-140.

 

Brooks DJ. Can imaging separate multiple system atrophy from Parkinson's disease? Mov Disord 2012;27:3-5.

 

Chang KV, Chen WS, Wu RM, Chen SY, Shen HY, Lan C, Wang YH. Pulsed wave Doppler ultrasound is useful to assess vasomotor response in patients with multiple system atrophy and well correlated with tilt table study. ScientificWorldJournal 2012;2012:548529.

 

Chen KH, Lin CH, Wu RM. Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2. BMJ Case Rep 2012;2012.

 

Chiba Y, Takei S, Kawamura N, Kawaguchi Y, Sasaki K, Hasegawa-Ishii S, Furukawa A, Hosokawa M, Shimada A. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy. Neuropathol Appl Neurobiol 2012;38:559-571.

 

Chitose S, Kikuchi A, Ikezono K, Umeno H, Nakashima T. Effect of laser arytenoidectomy on respiratory stridor caused by multiple system atrophy. J Clin Sleep Med 2012;8:713-715.

 

Colosimo C, Inghilleri M. A further case of nicotine sensitivity in multiple system atrophy. Clin Neuropharmacol 2012;35:51-52.

 

Damon-Perriere N, Foubert-Samier A, De Cock VC, Gerdelat-Mas A, Debs R, Pavy-Le Traon A, Senard JM, Rascol O, Tison F, Meissner WG. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Parkinsonism Relat Disord 2012;18:612-615.

 

Ferini-Strambi L, Marelli S. Sleep dysfunction in multiple system atrophy. Curr Treat Options Neurol 2012;14:464-473.

 

Fernagut PO, Tison F. Animal models of multiple system atrophy. Neuroscience 2012;211:77-82.

 

Fernagut PO, Vital A, Canron MH, Tison F, Meissner WG. Ambiguous mechanisms of dysphagia in multiple system atrophy. Brain 2012;135:e205; author reply e206.

 

Fischer MD, Synofzik M, Kernstock C, Dietzsch J, Heidlauf R, Schicks J, Srulijes K, Wiethoff S, Menn O, Berg D, Schols L, Schiefer U. Decreased retinal sensitivity and loss of retinal nerve fibers in multiple system atrophy. Graefes Arch Clin Exp Ophthalmol 2013;251:235-241.

 

Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM. Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiol Dis 2012;45:188-195.

 

Fukushima T, Asahina M, Fujinuma Y, Yamanaka Y, Katagiri A, Mori M, Kuwabara S. Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy. J Neurol 2013;260:475-483.

 

Furushima H, Shimohata T, Nakayama H, Ozawa T, Chinushi M, Aizawa Y, Nishizawa M. Significance and usefulness of heart rate variability in patients with multiple system atrophy. Mov Disord 2012;27:570-574.

 

Gawel M, Jamrozik Z, Szmidt-Salkowska E, Slawek J, Rowinska-Marcinska K. Is peripheral neuron degeneration involved in multiple system atrophy? A clinical and electrophysiological study. J Neurol Sci 2012;319:81-85.

 

Glass PG, Lees AJ, Mathias C, Mason L, Best C, Williams DR, Katzenschlager R, Silveira-Moriyama L. Olfaction in pathologically proven patients with multiple system atrophy. Mov Disord 2012;27:327-328.

 

Goricke B, Lingor P, Stadelmann-Nessler C, Bahr M, Kastrup A, Kermer P. Cerebellar-type multiple system atrophy presenting with leucoencephalopathy. J Neurol Neurosurg Psychiatry 2012;83:230-232.

 

Han YH, Lee JH, Kang BM, Mun CW, Baik SK, Shin YI, Park KH. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy. J Neurol Sci 2013;325:29-35.

 

Hohler AD, Singh VJ. Probable hereditary multiple system atrophy-autonomic (MSA-A) in a family in the United States. J Clin Neurosci 2012;19:479-480.

 

Hou B, You H, Wang H, Zhao YP, Jiang B, Sun HY, Cui LY, Feng F. Voxel-based Relaxometry of transverse relaxation rate with gradient echo R2(*) in patients with multiple system atrophy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2012;34:450-454.

 

Ichikawa Y. [Towards more efficient clinical trials for multiple system atrophy in Japan]. Brain Nerve 2012;64:1141-1149.

 

Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA. Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry 2012;83:453-459.

 

Ishigami N, Tokuda T, Ikegawa M, Komori M, Kasai T, Kondo T, Matsuyama Y, Nirasawa T, Thiele H, Tashiro K, Nakagawa M. Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy. Mov Disord 2012;27:851-857.

 

Isozaki E, Tobisawa S, Naito R, Mizutani T, Matsubara S. [Eye movement disturbance in multiple system atrophy: chronological study of 50 patients]. Rinsho Shinkeigaku 2012;52:218-226.

 

Ito H, Nakayama K, Jin C, Suzuki Y, Yazawa I. alpha-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy. Biochem Biophys Res Commun 2012;428:348-353.

 

Jang EH, Lee JK, Jang HJ, Kim MJ, Chung SJ. A case of multiple system atrophy-cerebellar type preceded by dementia. J Mov Disord 2012;5:48-52.

 

Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 2012;11:361-368.

 

Jellinger K. Long duration of multiple system atrophy. Neuropathology 2012;32:586.

 

Jellinger KA. Young-onset multiple system atrophy. J Neurol Sci 2012;323:264; author reply 265.

 

Jellinger KA. Neuropathology and pathophysiology of multiple system atrophy. Neuropathol Appl Neurobiol 2012;38:379-380; author reply 381.

 

Kaindlstorfer C, Garcia J, Winkler C, Wenning GK, Nikkhah G, Dobrossy MD. Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy. J Neurosci Res 2012;90:1284-1295.

 

Kasahara S, Miki Y, Kanagaki M, Kondo T, Yamamoto A, Morimoto E, Okada T, Ito H, Takahashi R, Togashi K. "Hot cross bun" sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging. Eur J Radiol 2012;81:2848-2852.

 

Kim HJ, Jeon BS. Multiple system atrophy with prolonged survival. Mov Disord 2012;27:1834.

 

Kim HJ, Jeon BS, Lee JY, Yun JY, Kim YE, Paek SH. Young-onset multiple system atrophy. J Neurol Sci 2012;319:168-170.

 

Kimpinski K, Iodice V, Burton DD, Camilleri M, Mullan BP, Lipp A, Sandroni P, Gehrking TL, Sletten DM, Ahlskog JE, Fealey RD, Singer W, Low PA. The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy. J Neurol Sci 2012;317:92-96.

 

Kiyono K, Hayano J, Kwak S, Watanabe E, Yamamoto Y. Non-gaussianity of low frequency heart rate variability and sympathetic activation: lack of increases in multiple system atrophy and Parkinson disease. Front Physiol 2012;3:34.

 

Kolenc M, Popovic M, Grmek M, Pirtosek Z, Trost M. A case of multiple system atrophy with normal dopamine transporter imaging. J Neurol 2012;259:2729-2731.

 

Krismer F, Seppi K, Tison F, Sampaio C, Zangerl A, Peralta C, Yekhlef F, Ghorayeb I, Ory-Magne F, Galitzky M, Bozi M, Scaravilli T, Colosimo C, Geser F, Rascol O, Poewe W, Quinn NP, Wenning GK, European Multiple System Atrophy Study G. The Unified Multiple System Atrophy Rating Scale: intrarater reliability. Mov Disord 2012;27:1683-1685.

 

Lee PH, Lee JE, Kim HS, Song SK, Lee HS, Nam HS, Cheong JW, Jeong Y, Park HJ, Kim DJ, Nam CM, Lee JD, Kim HO, Sohn YH. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann Neurol 2012;72:32-40.

 

Lee SW, Koh SB. Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy. J Mov Disord 2012;5:42-47.

 

Lewis SJ, Pavese N, Rivero-Bosch M, Eggert K, Oertel W, Mathias CJ, Brooks DJ, Gerhard A. Brain monoamine systems in multiple system atrophy: a positron emission tomography study. Neurobiol Dis 2012;46:130-136.

 

Lirng JF, Wang PS, Chen HC, Soong BW, Guo WY, Wu HM, Chang CY. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS One 2012;7:e47925.

 

Low PA, Gilman S. Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective? Ann Neurol 2012;72:4-5.

 

Makioka K, Yamazaki T, Takatama M, Nakazato Y, Okamoto K. Activation and alteration of lysosomes in multiple system atrophy. Neuroreport 2012;23:270-276.

 

Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jager HR. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012;27:1754-1762.

 

Masui K, Nakata Y, Fujii N, Iwaki T. Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Neuropathology 2012;32:69-76.

 

Mazzone P, Sposato S, Insola A, Scarnati E. A commentary on the lead positioning for deep brain stimulation in the pedunculopontine tegmental nucleus in a patient affected by multiple system atrophy. Stereotact Funct Neurosurg 2012;90:130-133.

 

Meissner WG, Foubert-Samier A, Dupouy S, Gerdelat-Mas A, Debs R, Marquant F, De Cock VC, Rascol O, Tison F, Pavy-Le Traon A. Assessment of quality of life with the multiple system atrophy health-related quality of life scale. Mov Disord 2012;27:1574-1577.

 

Nagai Y, Kitazawa R, Nakagawa M, Komoda M, Kondo T, Haraguchi R, Kitazawa S. Multiple-system atrophy in long-term professional painter: a case report. Case Rep Pathol 2012;2012:613180.

 

Nakayama K, Suzuki Y, Yazawa I. Binding of neuronal alpha-synuclein to beta-III tubulin and accumulation in a model of multiple system atrophy. Biochem Biophys Res Commun 2012;417:1170-1175.

 

Nocker M, Seppi K, Donnemiller E, Virgolini I, Wenning GK, Poewe W, Scherfler C. Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]beta-CIT SPECT. Eur J Nucl Med Mol Imaging 2012;39:1012-1020.

 

Novak P, Williams A, Ravin P, Zurkiya O, Abduljalil A, Novak V. Treatment of multiple system atrophy using intravenous immunoglobulin. BMC Neurol 2012;12:131.

 

Obiora O, McCormick LM, Karim Y, Gonzales P, Beeghly J. Maintenance electroconvulsive therapy in a patient with multiple system atrophy and bipolar disorder. J ECT 2012;28:e1-2.

 

Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. J Nucl Med 2012;53:399-406.

 

Ozawa T, Sekiya K, Sekine Y, Shimohata T, Tomita M, Nakayama H, Aizawa N, Takeuchi R, Tokutake T, Katada S, Nishizawa M. Maintaining glottic opening in multiple system atrophy: efficacy of serotonergic therapy. Mov Disord 2012;27:919-921.

 

Perju-Dumbrava LD, Kovacs GG, Pirker S, Jellinger K, Hoffmann M, Asenbaum S, Pirker W. Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy. Mov Disord 2012;27:65-71.

 

Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati LN, Lang AE, Revesz T, Holton JL, Lees AJ. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 2012;27:1186-1190.

 

Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel JP, Fahn S, Eidelberg D. Network correlates of disease severity in multiple system atrophy. Neurology 2012;78:1237-1244.

 

Pouclet H, Lebouvier T, Coron E, Rouaud T, Flamant M, Toulgoat F, Roy M, Vavasseur F, Bruley des Varannes S, Neunlist M, Derkinderen P. Analysis of colonic alpha-synuclein pathology in multiple system atrophy. Parkinsonism Relat Disord 2012;18:893-895.

 

Qi XK, Li LP, Yao W, Liu JG, Qiu F. [The diagnostic value of urethral sphincter electromyography in patients with multiple system atrophy]. Zhonghua Nei Ke Za Zhi 2012;51:975-977.

 

Recio Bermejo M, Navarro Munoz S, Espejo Martinez B, Mangas Aveleira C, Garcia Ruiz R. ["Hot-cross bun sign" in multiple system atrophy: a presentation of 3 cases]. Neurologia 2012;27:314-315.

 

Regragui W, Lachhab L, Razine R, Benjelloun H, Ait Benhaddou EH, Benomar A, Yahyaoui M. Profile of multiple system atrophy in Moroccan patients attending a movement disorders outpatient clinic in Rabat university hospital. Rev Neurol (Paris) 2013;169:121-125.

 

Rocchi L, Conte A, Nardella A, Li Voti P, Di Biasio F, Leodori G, Fabbrini G, Berardelli A. Somatosensory temporal discrimination threshold may help to differentiate patients with multiple system atrophy from patients with Parkinson's disease. Eur J Neurol 2013;20:714-719.

 

Rockenstein E, Ubhi K, Inglis C, Mante M, Patrick C, Adame A, Masliah E. Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy. Neuroreport 2012;23:259-264.

 

Sacca F, Marsili A, Quarantelli M, Brescia Morra V, Brunetti A, Carbone R, Pane C, Puorro G, Russo CV, Salvatore E, Tucci T, De Michele G, Filla A. A randomized clinical trial of lithium in multiple system atrophy. J Neurol 2013;260:458-461.

 

Sakuta H, Miyamoto M, Suzuki K, Miyamoto T, Nakajima I, Nakamura T, Hirata K. [Obese woman presenting as vocal cord abductor paralysis and floppy arytenoid associated with early signs of multiple system atrophy]. Rinsho Shinkeigaku 2012;52:421-424.

 

Schwarz L, Goldbaum O, Bergmann M, Probst-Cousin S, Richter-Landsberg C. Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. J Mol Neurosci 2012;47:256-266.

 

Shimohata T, Nakayama H, Tomita M, Ozawa T, Nishizawa M. Daytime sleepiness in Japanese patients with multiple system atrophy: prevalence and determinants. BMC Neurol 2012;12:130.

 

Spaccavento S, Del Prete M, Loverre A, Craca A, Nardulli R. Multiple system atrophy with early cognitive deficits: a case report. Neurocase 2013;19:613-622.

 

Stefanova N, Georgievska B, Eriksson H, Poewe W, Wenning GK. Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotox Res 2012;21:393-404.

 

Stefanova N, Kaufmann WA, Humpel C, Poewe W, Wenning GK. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol 2012;124:51-65.

 

Sun QY, Guo JF, Han WW, Zuo X, Wang L, Yao LY, Pan Q, Xia K, Yan XX, Tang BS. Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China. J Clin Neurosci 2013;20:217-219.

 

Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, Hayashi Y, Kimura A, Hozumi I, Araki H, Murase M, Nagaki M, Moriwaki H, Inuzuka T. Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test. J Neurol 2012;259:1448-1452.

 

Tanji K, Odagiri S, Maruyama A, Mori F, Kakita A, Takahashi H, Wakabayashi K. Alteration of autophagosomal proteins in the brain of multiple system atrophy. Neurobiol Dis 2013;49:190-198.

 

Tateno F, Sakakibara R, Kawai T, Kishi M, Murano T. Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson Disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease. Alzheimer Dis Assoc Disord 2012;26:213-216.

 

Tha KK, Terae S, Tsukahara A, Soma H, Morita R, Yabe I, Ito YM, Sasaki H, Shirato H. Hyperintense putaminal rim at 1.5 T: prevalence in normal subjects and distinguishing features from multiple system atrophy. BMC Neurol 2012;12:39.

 

Tsukamoto K, Matsusue E, Kanasaki Y, Kakite S, Fujii S, Kaminou T, Ogawa T. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology 2012;54:947-955.

 

Ueda M, Nakajima N, Nagayama H, Nishiyama Y, Ishii K, Katayama Y. Therapeutic response to pramipexole in a patient with multiple system atrophy with predominant parkinsonism: positron emission tomography and pharmacokinetic assessments. Intern Med 2013;52:1731-1735.

 

Ullman M, Vedam-Mai V, Resnick AS, Yachnis AT, McFarland NR, Merritt S, Zeilman P, Foote KD, Okun MS. Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy. Parkinsonism Relat Disord 2012;18:86-88.

 

Umoto M, Miwa H, Ando R, Kajimoto Y, Kondo T. White matter hyperintensities in patients with multiple system atrophy. Parkinsonism Relat Disord 2012;18:17-20.

 

Wang Y, Butros SR, Shuai X, Dai Y, Chen C, Liu M, Haacke EM, Hu J, Xu H. Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012;33:266-273.

 

Wenning GK, Granata R, Krismer F, Durr S, Seppi K, Poewe W, Bleasdale-Barr K, Mathias CJ. Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study. Cerebellum 2012;11:223-226.

 

Wu YT, Shyu KK, Jao CW, Liao YL, Wang TY, Wu HM, Wang PS, Soong BW. Quantifying cerebellar atrophy in multiple system atrophy of the cerebellar type (MSA-C) using three-dimensional gyrification index analysis. Neuroimage 2012;61:1-9.

 

Wujtewicz MA, Chwojnicki K, Owczuk R, Wujtewicz M. Laryngeal dystonia in the course of multiple system atrophy: a cause of postoperative respiratory insufficiency. Neurol Sci 2012;33:681-683.

 

Yoon HH, Lee CS, Hong SH, Min J, Kim YH, Hwang O, Jeon SR. Evaluation of a multiple system atrophy model in rats using multitracer microPET. Acta Neurochir (Wien) 2012;154:935-940.

 

Youn J, Shin H, Kim JS, Cho JW. Preliminary study of intravenous amantadine treatment for ataxia management in patients with probable multiple system atrophy with predominant cerebellar ataxia. J Mov Disord 2012;5:1-4.